nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—HTR2B—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—GNAQ—focal segmental glomerulosclerosis	0.0301	0.0424	CbGpPWpGaD
Agomelatine—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—GNAQ—focal segmental glomerulosclerosis	0.0242	0.0342	CbGpPWpGaD
Agomelatine—MTNR1B—G alpha (i) signalling events—AGTR2—focal segmental glomerulosclerosis	0.0154	0.0218	CbGpPWpGaD
Agomelatine—MTNR1A—G alpha (i) signalling events—AGTR2—focal segmental glomerulosclerosis	0.0154	0.0218	CbGpPWpGaD
Agomelatine—MTNR1B—Circadian rythm related genes—GNAQ—focal segmental glomerulosclerosis	0.0147	0.0207	CbGpPWpGaD
Agomelatine—MTNR1A—Circadian rythm related genes—GNAQ—focal segmental glomerulosclerosis	0.0147	0.0207	CbGpPWpGaD
Agomelatine—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.0144	0.0527	CcSEcCtD
Agomelatine—MTNR1B—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.0143	0.0202	CbGpPWpGaD
Agomelatine—MTNR1A—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.0143	0.0202	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.0123	0.0173	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.0123	0.0173	CbGpPWpGaD
Agomelatine—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.0121	0.0441	CcSEcCtD
Agomelatine—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.0121	0.0441	CcSEcCtD
Agomelatine—MTNR1B—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.011	0.0155	CbGpPWpGaD
Agomelatine—MTNR1A—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.011	0.0155	CbGpPWpGaD
Agomelatine—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.0107	0.039	CcSEcCtD
Agomelatine—Naproxen—ALB—focal segmental glomerulosclerosis	0.00972	0.552	CrCbGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00943	0.0133	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00943	0.0133	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00934	0.0132	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00934	0.0132	CbGpPWpGaD
Agomelatine—MTNR1A—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	0.00864	0.0122	CbGpPWpGaD
Agomelatine—MTNR1B—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	0.00864	0.0122	CbGpPWpGaD
Agomelatine—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00853	0.0312	CcSEcCtD
Agomelatine—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00848	0.031	CcSEcCtD
Agomelatine—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00836	0.0306	CcSEcCtD
Agomelatine—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00836	0.0306	CcSEcCtD
Agomelatine—MTNR1B—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.00835	0.0118	CbGpPWpGaD
Agomelatine—MTNR1A—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.00835	0.0118	CbGpPWpGaD
Agomelatine—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00834	0.0305	CcSEcCtD
Agomelatine—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00815	0.0298	CcSEcCtD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.008	0.0113	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.008	0.0113	CbGpPWpGaD
Agomelatine—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00791	0.0289	CcSEcCtD
Agomelatine—Indomethacin—ALB—focal segmental glomerulosclerosis	0.00788	0.448	CrCbGaD
Agomelatine—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00751	0.0274	CcSEcCtD
Agomelatine—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00738	0.027	CcSEcCtD
Agomelatine—MTNR1B—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	0.00727	0.0103	CbGpPWpGaD
Agomelatine—MTNR1A—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	0.00727	0.0103	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00718	0.0101	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00718	0.0101	CbGpPWpGaD
Agomelatine—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.007	0.0256	CcSEcCtD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00664	0.00936	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00664	0.00936	CbGpPWpGaD
Agomelatine—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00658	0.024	CcSEcCtD
Agomelatine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00616	0.0225	CcSEcCtD
Agomelatine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00612	0.0224	CcSEcCtD
Agomelatine—CYP1A2—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.00609	0.00859	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00609	0.00859	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00609	0.00859	CbGpPWpGaD
Agomelatine—HTR2B—G alpha (q) signalling events—TRPC6—focal segmental glomerulosclerosis	0.00601	0.00848	CbGpPWpGaD
Agomelatine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.006	0.0219	CcSEcCtD
Agomelatine—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00597	0.0218	CcSEcCtD
Agomelatine—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00587	0.0215	CcSEcCtD
Agomelatine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00554	0.0203	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00552	0.0202	CcSEcCtD
Agomelatine—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00544	0.0199	CcSEcCtD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	0.00538	0.00759	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00531	0.00749	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00531	0.00749	CbGpPWpGaD
Agomelatine—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.0053	0.0194	CcSEcCtD
Agomelatine—MTNR1B—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00528	0.00745	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00528	0.00745	CbGpPWpGaD
Agomelatine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00523	0.0191	CcSEcCtD
Agomelatine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00518	0.0189	CcSEcCtD
Agomelatine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00515	0.0188	CcSEcCtD
Agomelatine—MTNR1A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00505	0.00713	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00505	0.00713	CbGpPWpGaD
Agomelatine—HTR2B—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	0.00503	0.00709	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00499	0.00704	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00499	0.00704	CbGpPWpGaD
Agomelatine—HTR2C—G alpha (q) signalling events—TRPC6—focal segmental glomerulosclerosis	0.00485	0.00684	CbGpPWpGaD
Agomelatine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00482	0.0176	CcSEcCtD
Agomelatine—MTNR1A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00482	0.0068	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00482	0.0068	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00479	0.00676	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00479	0.00676	CbGpPWpGaD
Agomelatine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00479	0.0175	CcSEcCtD
Agomelatine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00474	0.0173	CcSEcCtD
Agomelatine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00469	0.0172	CcSEcCtD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.00462	0.00652	CbGpPWpGaD
Agomelatine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0046	0.0168	CcSEcCtD
Agomelatine—HTR2B—G alpha (q) signalling events—AGTR1—focal segmental glomerulosclerosis	0.0046	0.00649	CbGpPWpGaD
Agomelatine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.0046	0.0168	CcSEcCtD
Agomelatine—MTNR1B—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00458	0.00647	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00458	0.00647	CbGpPWpGaD
Agomelatine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00456	0.0167	CcSEcCtD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.0045	0.00634	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00444	0.00626	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00444	0.00626	CbGpPWpGaD
Agomelatine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00436	0.0159	CcSEcCtD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	0.00434	0.00612	CbGpPWpGaD
Agomelatine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00424	0.0155	CcSEcCtD
Agomelatine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00422	0.0154	CcSEcCtD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.00411	0.0058	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	0.00409	0.00577	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00406	0.00573	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00406	0.00573	CbGpPWpGaD
Agomelatine—HTR2C—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	0.00406	0.00572	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00403	0.00569	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00403	0.00569	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00396	0.00559	CbGpPWpGaD
Agomelatine—HTR2B—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.0039	0.0055	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00387	0.00546	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00387	0.00546	CbGpPWpGaD
Agomelatine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00383	0.014	CcSEcCtD
Agomelatine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00377	0.0138	CcSEcCtD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.00373	0.00526	CbGpPWpGaD
Agomelatine—HTR2C—G alpha (q) signalling events—AGTR1—focal segmental glomerulosclerosis	0.00371	0.00523	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00369	0.0052	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00369	0.0052	CbGpPWpGaD
Agomelatine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00365	0.0133	CcSEcCtD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.00363	0.00512	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00355	0.00501	CbGpPWpGaD
Agomelatine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00353	0.0129	CcSEcCtD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.00349	0.00492	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00344	0.00486	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00344	0.00486	CbGpPWpGaD
Agomelatine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00339	0.0124	CcSEcCtD
Agomelatine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00334	0.0122	CcSEcCtD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.00332	0.00468	CbGpPWpGaD
Agomelatine—HTR2B—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.00324	0.00456	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00319	0.00451	CbGpPWpGaD
Agomelatine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00317	0.0116	CcSEcCtD
Agomelatine—HTR2C—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.00314	0.00444	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00313	0.00441	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00313	0.00441	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00304	0.0043	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00302	0.00425	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.00289	0.00408	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00287	0.00405	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00286	0.00403	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00286	0.00403	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00285	0.00402	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00285	0.00402	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00283	0.004	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00283	0.004	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.00281	0.00397	CbGpPWpGaD
Agomelatine—HTR2C—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.00261	0.00368	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00259	0.00366	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00259	0.00366	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00258	0.00364	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00246	0.00347	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00243	0.00343	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00238	0.00336	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00238	0.00336	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.00233	0.00329	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00232	0.00327	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00218	0.00307	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00218	0.00307	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00214	0.00302	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00208	0.00294	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00197	0.00277	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00187	0.00264	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00185	0.0026	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00185	0.0026	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00179	0.00253	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00179	0.00253	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00173	0.00244	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00171	0.00242	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.0017	0.0024	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	0.0017	0.00239	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.0017	0.00239	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.0017	0.00239	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00163	0.0023	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00161	0.00227	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00159	0.00224	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00156	0.0022	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00155	0.00218	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00153	0.00216	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00153	0.00216	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00148	0.00209	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00143	0.00202	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00142	0.002	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00142	0.002	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00138	0.00195	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00137	0.00194	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00132	0.00186	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00131	0.00185	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.0013	0.00184	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.0013	0.00183	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00126	0.00177	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00125	0.00176	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00125	0.00176	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00119	0.00168	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00119	0.00168	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.00118	0.00166	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.00118	0.00166	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00116	0.00163	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00111	0.00157	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00106	0.00149	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00105	0.00148	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.00105	0.00148	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00101	0.00142	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00101	0.00142	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00096	0.00135	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000922	0.0013	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000922	0.0013	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000919	0.0013	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000914	0.00129	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000902	0.00127	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000902	0.00127	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000896	0.00126	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000895	0.00126	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000837	0.00118	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000814	0.00115	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000788	0.00111	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000769	0.00108	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000744	0.00105	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000744	0.00105	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000744	0.00105	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000742	0.00105	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000738	0.00104	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000703	0.000992	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000676	0.000953	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000639	0.000902	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00062	0.000875	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000596	0.000841	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000578	0.000816	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000567	0.0008	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000548	0.000773	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000547	0.000772	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000546	0.000771	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000495	0.000698	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000481	0.000678	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000467	0.000659	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000467	0.000658	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000466	0.000658	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000457	0.000645	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000442	0.000623	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.00042	0.000592	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000411	0.00058	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000399	0.000563	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000399	0.000562	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.00038	0.000537	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000378	0.000534	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000369	0.00052	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	0.000359	0.000506	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000351	0.000495	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000323	0.000456	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000307	0.000433	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000291	0.000411	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	0.000285	0.000402	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	0.000244	0.000344	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	0.000243	0.000343	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.00024	0.000339	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000235	0.000332	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	0.000208	0.000294	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000194	0.000273	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	0.000187	0.000264	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	0.00016	0.000225	CbGpPWpGaD
